Lisinopril Tablet
Product Images NDC 42708-176

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 42708-176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)
Chemical structure of Lisinopril dihydrate depicting its molecular arrangement with labeled functional groups and ring systems.*
FDA Label Image

42708-176-30 (42708 176 30 Rev 1)

42708-176-30 (42708 176 30   Rev 1)
Label for Lisinopril Tablets USP, 40 mg, oral solid dosage form, supplied in a package of 30 tablets. The label includes dosage instructions to be completed by a healthcare provider, storage directions to keep at controlled room temperature, and a note that it is for prescription use only. Distributed by QPharma, Inc., Cedar Knolls, NJ. Includes a barcode and placeholder lot and expiration date information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.